Measurements and Main Results

Of 240 EA participants responding, 77 (32.1%) reported having tried marijuana, with the majority of these participants (52 of 77, 67.5%) reporting marijuana to be very or moderately effective. Of 124 clinic participants responding, 58 (46.8%) reported having tried marijuana, with the majority of patients (44 of 58, 75.9%) reporting marijuana to be very or moderately effective. 67 (27.8%) EA participants reported having tried CBD, with half (50%, 34 of 67) reporting CBD to be very or moderately effective. 57 (46.0%) clinic participants reported having tried CBD, with the majority (64.9%, 37 of 57) reporting CBD to be very or moderately effective. Amongst both participant groups, Marijuana was most likely to be reported as very effective (40.2% of EA participants, 53.4% of clinic participants), while CBD was most likely to be reported as moderately effective (31.4% of EA participants, 36.8% of clinic participants).